This session highlights cutting-edge research in Hepatitis C treatment, including next-generation antivirals, optimized therapy durations, and strategies for long-term patient outcomes post-cure. Presenters will share findings from clinical trials, modeling studies, and translational research aimed at advancing the future of HCV care.
Objectives
Understand emerging antiviral agents and combination regimens for Hepatitis C.
Receive updates on long-term outcomes of novel HCV therapies.
Explore predictive tools and post-cure interventions aimed at reducing long-term liver-related complications and advancing HCV-related cancer prevention.